3 Min Read
LIMA (Reuters) - Peruvian prosecutors are probing the use of so-called “courtesy doses” of China’s Sinopharm vaccine after two top government officials resigned over the weekend upon acknowledging they had taken the Chinese shot months ago, well before they were widely available in the country.
FILE PHOTO: Health workers wait for a dose of the Sinopharm s coronavirus disease (COVID-19) vaccine in Lima, Peru, February 9, 2021. REUTERS/Sebastian Castaneda/File Photo/File Photo
The growing scandal in Peru erupted Thursday after ousted former President Martin Vizcarra said he too had received an early vaccination. Several other top officials have since stepped down.
Fauci was worried about contracting Covid-19 at Trump White House
From CNN s Ben Tinker
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during an interview on February 14. HBO/Axios
In an interview that aired on “Axios on HBO” Sunday, Axios Managing Editor Margaret Talev asked Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, if he ever worried about contracting the coronavirus himself.
At age 80, Fauci is considered at high risk for serious disease and death if he were to get sick with Covid-19.
“I think you’d have to be oblivious not to consider the fact that if you get infected, that you are already in the category of someone who has a high-risk of having a serious outcome,” Fauci said. “I didn’t fixate on that, but it was in the back of my mind, because I had to be out there. I mean, particularly when I was going to the White House every day when the White House was sort o
Peru's foreign minister has stepped down amid a furor over government officials being vaccinated against the coronavirus, even before the country began rolling out doses to health care workers.
FDA authorizes new Eli Lilly monoclonal antibody duo
From CNN Health’s Maggie Fox
In this file photo, an employee at Eli Lilly works on an antibody treatment for Covid-19. Source: Eli Lilly
The US Food and Drug Administration has granted emergency use authorization to a new version of Eli Lilly and Co’s antibody treatment for coronavirus that adds a second monoclonal antibody to one already authorized, the company said Tuesday.
The new treatment adds etesevimab or LY-CoV016 to the already authorized bamlanivimab or LY-CoV555 to make a double-antibody version – one that might be more protective, the company says. Rival Regeneron has a dual antibody-cocktail on the market already.
Germany edges closer to coronavirus goal but variants pose a new threat
From CNN s Claudia Otto in Berlin
A medical assistant prepares a rapid antigen Covid-19 test at the Koeln Messe trade fair grounds on February 8 in Cologne, Germany. Andreas Rentz/Getty Images
Germany s seven-day Covid-19 case incidence rate has dropped below 100 for the first time in three months, according to its infectious disease agency a key metric in the country s fight against the pandemic.
That means in the past week, the Robert Koch Institute only reported 72.8 infections per 100,000 residents.
German Chancellor Angela Merkel has consistently told the public the goal is to push infections under the rate of 50 cases per 100,000 residents, in order to start reopening the country.